A critical vulnerability has been found in a connected product that has been deployed for more than ten years. The device performs an essential safety or operational function, but a validated patch will not be available for several months.
What should the manufacturer do next?
In this panel discussion, security and engineering leaders from RunSafe Security, Lynx, Rockwell Automation, and Zimmer Biomet compare how medical device and industrial teams manage this challenge.
The speakers examine how organizations determine which products are affected, make defensible risk decisions, select compensating controls, and manage vulnerability reporting across device lifecycles measured in decades.
Watch the webinar to learn:
- What medical device postmarket reporting can teach industrial manufacturers
- What evidence teams need beyond an SBOM to make vulnerability decisions
- How product context changes whether a device is considered affected
- How organizations respond when a patch cannot be deployed immediately
- Which mitigations reduce exploitability and which may provide only superficial reassurance
- What manufacturers should prioritize to improve both compliance readiness and product security
Meet the Speakers
Shane Fry |
Maciej Halasz |
John Howie |
Joel Max |
Download our Webinar
What Can RunSafe Security Do For You?
Disrupt Attacker Economics
Reduce Attack
Surfaces
Neutralize Zero-Days with Moving Target Defense.
Protect Key
Applications
Proactive Code Level Security to maintain original functionality and mitigate the attack.